BIRC6 and steatosis: This study identifies BRUCE as a critical co-suppressor of MASLD/MASH, working synergistically with PTEN to regulate MASLD/MASH progression via a STAT3 central signaling hub that orchestrates the transition from steatosis to inflammatory fibrosis, while providing rigorous mechanistic insights.